Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Antiparasitic Drugs Market Size Changed, over the years?
The market size for antiparasitic drugs has seen significant expansion in the previous years. It is projected to escalate from $24.06 billion in 2024 to $25.75 billion in 2025, with an impressive compound annual growth rate (CAGR) of 7.0%. Factors such as the widespread occurrence of parasitic infections, the resistance to current treatments, and international health initiatives contributed to this growth during the historical period.
How Much Will the Antiparasitic Drugs Market Be Worth in 2029?
In the coming years, the market size for antiparasitic drugs is projected to experience robust growth, eventually reaching $33.64 billion in 2029 with a compound annual growth rate (CAGR) of 6.9%. This anticipated expansion over the forecast period can be ascribed to factors such as the emergence of new parasitic threats, changes in climate patterns and the spread of vector-borne diseases, a greater focus on international health security, and improved access to healthcare services. Crucial trends for the forecast period encompass advancements in the process of drug development, emphasis on targeted therapies, the use of combination treatments, increased public-private collaborations, the implementation of telemedicine, and the rising use of remote diagnostics.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12927&type=smp
Which is the Largest Company in the Antiparasitic Drugs Market?
Major companies operating in the antiparasitic drugs market are Pfizer Inc., Johnson & Johnson, Cadila Pharmaceuticals, Merck & Co.Inc., Bayer AG, Novartis AG, Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim group, Zoetis Inc., Eisai Co. Ltd., Covetrus Inc., IDEXX Laboratories Inc., Dr. Reddy’s Laboratories, Intas Pharmaceuticals Ltd., Alkem Laboratories Ltd., Ceva Sante Animale S.A., Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Norbrook Laboratories Ltd., Mankind Pharma, Neogen Corporation, Bimeda Inc., Indoco Remedies Ltd., ECO Animal Health, Lincoln Pharmaceuticals Ltd., Laboratorios Calier.
What Are the Main Market Drivers in the Antiparasitic Drugs Industry?
The rise in vector-borne disease cases is predicted to boost the antiparasitic drugs market growth. Vector-borne diseases are infectious ailments that get transferred to humans or other animals through arthropod bites, such as mosquitoes, ticks, and flies. Malaria, dengue, and yellow fever are a few examples of these diseases. In controlling the spread of these diseases, antiparasitic drugs play an integral role by attacking and killing the culpable parasites. Typical antiparasitic medications for treating malaria include chloroquine, doxycycline, and atovaquone-proguanil. According to the Centers for Disease Control and Prevention, a government agency based in the US, more than 9.7 million dengue cases were reported from January to June 2024 across Americas, showing a significant increase from the 4.6 million cases in 2023. In the US, 1,498 dengue cases were reported in Puerto Rico, while 745 cases were identified among U.S. travelers returning from affected regions. Thus, the rise in vector-borne diseases propels the antiparasitic drugs market growth.
Antiparasitic Drugs Market Driver: High Prevalence Of Parasitic Infections Raise Antiparasitic Drug Market
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12927&type=smp
How Is the Antiparasitic Drugs Market Segments Structured?
The antiparasitic drugs market covered in this report is segmented –
1) By Product Type: Anthelmintics, Antiprotozoals, Ectoparasiticide, Other Products
2) By Treatment: Avermectins, Bezimidazoles, Pyrimidines, Organophosphates, Imidazolesthiazoles
3) By Route of Administration: Oral, Injectable, Topical
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Anthelmintics: Benzimidazoles, Ivermectin, Pyrantel Pamoate, Praziquantel
2) By Antiprotozoals: Metronidazole, Tinidazole, Nitazoxanide, Pentamidine
3) By Ectoparasiticides: Permethrin, Malathion, Lindane, Fipronil
4) By Other Products: Combination Antiparasitic Drugs, Novel Antiparasitic Agents
What Strategic Trends Are Transforming the Antiparasitic Drugs Market?
Leading businesses in the antiparasitic drug industry are concentrating on introducing unique items such as chewable veterinary products to boost the ease of delivery and improve pet compliance. Chewable veterinary items are flavorful, straightforward to give tablets or treats engineered to offer medication to animals. These make the treatment process tastier and stress-free, thus enhancing pet compliance. For example, in April 2024, Germany-based pharma firm C.H. Boehringer Sohn AG and Co. KG introduced NexGard Spectra for comprehensive parasite management. NexGard SPECTRA is a delectable, soft chew capable of providing both internal and external parasite control for dogs. It is efficient against anything from fleas, ticks, heartworms, to various intestinal worms – all in just a single monthly serving. The chew exhibits quick results, eliminating fleas within four hours of its administration, and presents a striking 99% effectiveness against numerous parasites in a short span.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report
Which Global Regions Offer the Highest Growth in the Antiparasitic Drugs Market?
North America was the largest region in the antiparasitic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antiparasitic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12927
This Report Delivers Insight On:
1. How big is the antiparasitic drugs market, and how is it changing globally?
2. Who are the major companies in the antiparasitic drugs market, and how are they performing?
3. What are the key opportunities and risks in the antiparasitic drugs market right now?
4. Which products or customer segments are growing the most in the antiparasitic drugs market?
5. What factors are helping or slowing down the growth of the antiparasitic drugs market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
